New research published today in Nature Communications
For the very first time, researchers at BCI have shown that modifying the ‘epigenome’ of a healthy breast cell is not only possible, but precise enough to initiate a chain reaction of events that make the cell abnormal.
New MALDI-TOF research suggests a link between prostate cancer and low "oxygen" loving bacteria
Research by Professor Tim Oliver brings to light a possible new link between microbes and prostate cancer, an association that may indicate a radical change in thinking about the causes of the disease.
With the support of a recent £188,000 Pioneer Award from Cancer Research UK, Dr Katiuscia Bianchi and her team are developing an innovative method to allow researchers to screen and identify new drugs targeting a particular metabolic pathway that cancer cells use to thrive.
ADI-PEG20 with Immune Checkpoint Blockade for Malignant Mesothelioma
Tomorrow, Wednesday 18th October, Dr Peter Szlosarek will present "Pegylated Arginine Deiminase Potentiates PD-1/PDL-1 Immune Checkpoint Blockade in Malignant Mesothelioma" at the 18th IASLC World Conference on Lung Cancer, Yokohama, Japan...